Fig 1: Probing protein accessibility in endogenous mRNP complexes.a. Schematic of the experiment to probe protein accessibility in mRNP complexes. The nuclear or cytoplasmic extract from K562 cells, tagged homozygously and endogenously with either GFP-3C-THOC5 or GFP-3C-EIF4A3, was incubated with a fluorescently labelled (AF647) 15 kDa anti-GFP nanobody. The extracts were then applied to a sucrose density gradient to separate free proteins from mRNPs, which migrate in heavy (later) sucrose gradient fractions. The gradient fractions were analyzed by SDS–PAGE. Due to high affinity of the anti-GFP nanobody to GFP (~1 pM), the nanobody stays bound to the GFP fusion during gel electrophoresis (see Methods for details). Fluorescence imaging allows quantification of the respective sedimentation profiles for the GFP fusion proteins (GFP-THOC5 or GFP-EI4A3, green channel) and the anti-GFP nanobody-bound fusion proteins (red channel, colored in magenta). When the GFP-tagged protein is accessible in mRNPs, then the anti-GFP nanobody signal closely follows the profile of the GFP-tagged protein. In contrast, when a GFP-tagged protein is inaccessible in mRNPs, the anti-GFP nanobody signal follows the GFP signal in early (light) sucrose gradient fractions that contain free proteins but shows reduced intensity in later (heavy) fractions.b. The anti-GFP nanobody signal closely follows the GFP-THOC5 signal, showing that GFP-THOC5 is accessible in mRNP complexes. Shown is the fluorescence signal from SDS-PAGE gels of GFP-THOC5 nuclear extract incubated with the AF647-labeled anti-GFP nanobody (top) and normalized sedimentation profiles (bottom). Sedimentation plots show mean normalized intensity values determined from three gels (solid lines) and standard deviations (transparent areas). The grey box indicates the peak gradient fractions of purified TREX–mRNPs (see Extended Data Fig. 4). This experiment was done four times. For gel source data, see Supplementary Figure 9.c. As for panel b, but for GFP-EIF4A3 in nuclear extract. In the high molecular weight fractions of the sucrose density gradient, GFP-3C-EIF4A3 is poorly accessible to the anti-GFP nanobody. This experiment was done four times. For gel source data, see Supplementary Figure 10.d. As for panel b, but for GFP-EIF4A3 in cytoplasmic extract. In the high molecular weight fractions of the sucrose density gradient, GFP-EIF4A3 remains accessible to the anti-GFP nanobody, in contrast to GFP-EIF4A3 in nuclear extract, which is shown in panel c. This experiment was done twice. For gel source data, see Supplementary Figure 11.e. Western blot experiment that shows the different depletion efficiencies of THOC1-GFP (ectopically overexpressed; Lenti O/E), GFP-THOC5 (endogenously tagged; endo), or GFP-EIF4A3 (endogenously tagged; endo) from nuclear extract using GFP-Trap resin (containing an anti-GFP nanobody coupled to 90 μm agarose beads) after three rounds of depletion. While THOC1-GFP and GFP-THOC5 are completely depleted in the supernatant, GFP-EIF4A3 is very inefficiently depleted. Anti-PSMA7 blots (a proteasome subunit) serve as loading controls. These experiments were done three times. For gel source data, see Supplementary Figure 12.f. Cartoon model showing the position and nanobody-accessibility of GFP-tagged THOC5 or EIF4A3 in TREX–mRNPs, based on the accessibility to the anti-GFP nanobody and anti-GFP resin in panels e and f.
Fig 2: Structure of an ALYREF-exon-junction complex oligomer.a. Assembly scheme (left) and domain organization (right) of ALYREF–EJC–RNA complex components (see Extended Data Fig. 1 and Methods for details). Solid lines indicate regions included in the atomic model, dotted lines indicate protein construct boundaries. N- and C-terminal UAP56-binding motifs (N- and C-UBM); RNA-binding domains 1 and 2 (RBD1 and RBD2); RNA-recognition motif (RRM). The protein color code is used throughout.b. ALYREF55-182–EJC–RNA complex structure shown from top and side views. The structure shows an ALYREF55-182–EJC–RNA hexamer, one of the various oligomers observed in vitro (Extended Data Fig. 1c, f). In the top view (left), every second protomer is rendered transparent for clarity. In the side view (right) protomers 3 to 6 are transparent for clarity. In the cartoon inset ALYREF55-182–EJC–RNA protomers are labelled, 1 to 6, and the dimer is outlined in black.c. One ALYREF molecule bridges three EJCs, labelled 1, 2, and 3, through its WxHD (interface b) and RRM domains (interfaces c and d), suggesting mechanisms for mRNP recognition and packaging. The conserved ALYREF R144 arginine-finger (R-finger) of interface d wedges in between EIF4A3 and MAGOH of protomer 3. See Extended Data Fig. 2 for details.d. Assembly scheme (left), SDS-PAGE analysis (center), and cryo-EM (right) of the in vitro reconstituted TREX–EJC–RNA complex. Addition of recombinant THO–UAP56 to ALYREFN–EJC–RNA yields the TREX–EJC–RNA complex (center) (see also Extended Data Fig. 1l). Representative cryo-EM particles and their cartoon interpretations are shown on the right. Below, 2D averages of the ALYREF–EJC–RNA complex bound to THO–UAP56 or in isolation show an indistinguishable complex organization (see Extended Data Fig. 2d). THO complex (green), UAP56 (pink), all other protein colors as in panel a. For gel source data, see Supplementary Figure 1.
Fig 3: Comparisons of ALYREF–EJC interaction details with a viral ALYREF-ORF57 complex, the cytoplasmic CASC3–EJC–RNA complex, and the EJC-bound P-complex spliceosome.a. Organization of ALYREF. Top: Structural model of full-length ALYREF predicted with AlphaFold62,63. Annotated domains (N-UBM, WxHD motif, RRM and C-UBM) are colored in darker shades of purple. Spheres represent backbone atoms of glycine and arginine residues in the RBD domains. Middle: ALYREF domain diagram. Black bars indicate residues that are included as an atomic model in this study. Bottom: AlphaFold per residues confidence score (pLDDT) plot. High values are indicative of high confidence predictions, whereas low values represent residues that are likely disordered in solution.b. Comparison of the ALYREF RRM domain interaction with the EJC subunit MAGOH (interface c, left) and the Herpes simplex virus ORF57 (right)34. ALYREF binds viral ORF57 differently compared to the overlapping ALYREF–EJC interface c. This supports a general model that ALYREF can use multiple interfaces to engage either viral proteins, such as ORF57, or mRNP maturation marks, such as the CBC or EJCs, and may enable ALYREF to broadly select its RNA targets.c. Details of the WxHD motifs binding to the EJC. Left: Modelling of apo EIF4A3 bound to the WxHD motif indicates a clash with EIF4A3 residue Y202, suggesting that ALYREF can only bind to RNA-bound EJC (see Supplementary Video 2). Middle: the same view, showing the ALYREF WxHD motif bound to RNA-bound EJC (this study). Right: the same view, showing the CASC3 WxHD motif bound to RNA-bound EJC23, revealing conserved binding modes of ALYREF and CASC3.d. The ALYREF WxHD and RRM domains binds the same interfaces between EIF4A3 and MAGOH as the CASC3SELOR domain. Top: Overview image of the ALYREF–EJC–RNA structure (left) and comparison of the binding modes of ALYREF and CASC3 (middle and right, respectively). Bottom: Sequence alignment of ALYREF (top) and CASC3 (bottom), showing the conserved WxHD motif and an additional short conserved motif (QEL[F/I]Ax[F/Y]G), which is however not contacting the EJC in the ALYREF–EJC–RNA structure. Conserved (dark blue) and partially conserved (light blue) residues are indicated with boxes. Residues in ALYREF and CASC3 contacting the EJC are indicated.e. Superposition of the ALYREF–EJC–RNA complex (this study) onto the human P-complex spliceosome cryo-EM structure (PDB ID 6QDV)33, via their EJC EIF4A3 subunits. This model reveals that higher order ALYREF–EJC complexes such as the ALYREF–EJC dimer are not possible when the EJC is still bound by the spliceosomes, as the P-complex subunit SNU114 clashes with the RRM in an ALYREF–EJC dimer. In addition, SNU114 likely disfavors binding of a single molecule of ALYREF to the EJC, as there is a steric clash with the N-terminal ordered ALYREF residue (Asp 85) in the ALYREF–EJC structure.
Fig 4: ALYREF–EJC–RNA and TREX–EJC–RNA complex cryo-EM image processing and structural details.a. Denoised cryo-EM micrographs of ALYREF55-182–EJC–RNA (left) and TREX–EJC– RNA (right) complexes (see Methods). Scale bar, 500 Å. The ALYREF55-182–EJC–RNA dataset contained 7,891 micrographs and the TREX–EJC–RNA dataset 12,938 micrographs, respectively.b. TREX–EJC–RNA complexes contain multiple THO–UAP56 complexes, caging in a central ALYREFN–EJC–RNA complex. Single TREX–EJC–RNA particles from a denoised cryo-EM micrograph can contain two (left) or three (right) THO–UAP56complexes. In 2D class averages, the THO–UAP56 complexes blur out, because the central ALYREFN–EJC–RNA complex is aligned (bottom).c. Three-dimensional image classification tree of ALYREF55-182–EJC–RNA (left) and TREX–EJC–RNA (right) cryo-EM data. The ALYREF55-182–EJC–RNA dataset contained 7,891 micrographs from which 2,139,936 particles were picked and extracted. Three initial volumes were generated from 100,000 particles in cryoSPARC64 using the ab-initio reconstruction algorithm, which served as reference volumes to classify the entire dataset using three rounds of heterogenous classification (see Methods). The final particle stack contained 1,564,602 particles and was refined to 2.4 Å using D3 symmetry. The TREX–EJC–RNA dataset contained 1,050,740 particles, which were classified using initial volumes obtained from the ALYREF55-182–EJC–RNA dataset and from ab initio reconstructions. After 3D classification, 3D refinement and application of D3 symmetry in cryoSPARC64 yielded a 3.0 Å resolution map from 383,520 particles. The type of mask is indicated for each 3D refinement. Please refer to Methods for further details.d. ALYREF55-182–EJC–RNA and TREX–EJC–RNA give rise to indistinguishable 2D classes and reconstructions (top left and right), apart from the higher resolution of the ALYREF55-182–EJC–RNA dataset (bottom left), which contains more particles.e. Representative protein (MAGOH, top) and RNA (bottom) densities from the 2.4 Å resolution ALYREF55-182–EJC–RNA map.f. Orientation distribution plots for all particles contributing to the ALYREF55-182–EJC– RNA and TREX–EJC–RNA cryo-EM map, visualized in cryoSPARC64.g. Gold-standard Fourier shell correlation (FSC = 0.143) of the ALYREF55-182–EJC–RNA and TREX–EJC–RNA cryo-EM maps.h. Cryo-EM densities for ALYREF–EJC interface residues from the 2.4 Å ALYREF55-182–EJC–RNA map.i. Multiple sequence alignment showing the conservation of ALYREF–EJC interface residues in ALYREF, EIF4A3, and MAGOH using human (H.s.), Danio rerio (D.r.), Drosophila melanogaster (D.m.), Caenorhabditis elegans (C.e.), Arabidopsis thaliana (A.t.), and Schizosaccharomycespombe (S.p) sequences. A different type of arrow is used to indicate residues of interfaces b, c, and d.
Fig 5: Biochemical characterization of TREX–EJC–RNA and ALYREF–EJC–RNA complexes.a. Domain architecture of ALYREF constructs and their nomenclature used throughout. N- and C-UBM, N- and C-terminal UAP56-binding motif; RBD1 and RBD2, RNA-binding domain 1 and 2; RRM, RNA-recognition motif; MBP, Maltose Binding Protein; 3C, PreScission protease cleavage site; His, Histidine-tag.b. ALYREFN reconstitutes the EJC in vitro. Pulldown assay with MBP-ALYREFN (bait) incubated with EIF4A3, MAGOH–Y14 (residues 66-154), or both, with or without a 15 nucleotide long single stranded (ss) RNAs and/or AMP-PNP. Complex formation was determined by SDS-PAGE analysis with Coomassie blue staining. This exact experiment was done once, but similar results were obtained in two additional experiments either without AMP-PNP or without RNA.c. ALYREFN–EJC–RNA complexes form multimers. ALYREFN–EJC–RNA was assembled on 50 (top) or 15 nucleotides (nt) long single stranded RNAs (ssRNAs) (bottom) and analyzed in sucrose density gradients. SDS-PAGE analysis with Coomassie blue staining of gradient fractions indicates multiple oligomeric states. The sucrose gradient sedimentation profile (bottom) is based on quantification of MAGOH band intensities. The sedimentation coefficients were estimated in CowSuite based on the predicted molecular weights of the different oligomeric states (an ALYREFN–EJC–RNA monomer is ~150 kDa). The sedimentation range of one to six ALYREFN–EJC–RNA complexes is indicated. We analyzed even fraction numbers and included fractions 7 and 15 to better resolve monomer and hexamer peaks using SDS-PAGE. Gradient conditions are specified on top. This exact experiment was done once, but ALYREFN–EJC–RNA multimerization was similarly observed in an experiment with different gradient ultracentrifugation parameters.d. The ALYREF WxHD domain is sufficient for EJC reconstitution. Pulldown assay with different MBP-ALYREF truncation constructs (see panel a) or MBP-CASC3SELOR as a bait and EIF4A3 and MAGOH–Y14 (residues 66-154) to probe EJC-reconstitution efficiency. Complex formation was determined by SDS-PAGE analysis with Coomassie blue staining. This experiment was done twice. For gel source data, see Supplementary Figure 3.e. ALYREF55-182–EJC–RNA oligomers form in vitro, are resistant to RNase treatment, and do not require the ALYREF RED1 and UBM domains. The ALYREF55-182–EJC– RNA complex was assembled on 15 nt ssRNA and treated (bottom) or not treated (top) with 20 μg benzonase mL-1 to digest protein-unbound RNA. The complexes were then analyzed in sucrose density gradients. SDS-PAGE analysis with Coomassie blue staining of gradient fractions indicates indistinguishable oligomeric sedimentation profiles of the ALYREF55-182–EJC–RNA complex, with or without benzonase digestion. The sucrose gradient sedimentation profile (bottom) is based on quantification of MAGOH band intensities. The hexamer peak (confirmed by negative staining, see panel f) is indicated with a grey box. Gradient conditions are specified. This experiment was done twice, the second time with 2 μg benzonase mL-1.f. Negative stain 2D class averages show that MBP-ALYREF55-182–EJC–RNA (15nt) complexes form trimeric (top) and hexameric (bottom) complexes. Cartoon interpretations are shown on the right. Scale bar, 250 Å.g. Ribbon model showing the location of mutated residues in ALYREF in the ALYREF-EJC interface. Mutated residues are shown as sticks and Cα-spheres colored by the ALYREF–EJC interface.h. ALYREF–EJC interface mutations in the ALYREF55-182 constructs reduce the efficiency of EJC reconstitution. The pulldown assay was carried out as in panel d. Mutated residues are indicated in panel g. Complex formation was determined by SDS-PAGE analysis with Coomassie blue staining. This experiment was done twice.i. Mutation of ALYREF in the ALYREF–EJC interfaces impairs ALYREF–EJC–RNA complex oligomerization in vitro. ALYREFM-b and ALYREFM-c+Δd mutants were made in the ALYREF55-182 construct (see panel g for mutant details). Wild-type or mutant ALYREF55-182 or the isolated CASC3SELOR were used to assemble EJC–RNA complexes on a 15 nt long RNA and analyzed in sucrose density gradients for their multimerization. SDS-PAGE analysis with Coomassie blue staining of gradient fractions indicates loss of high-order oligomers in the sedimentation profiles of ALYREF mutants, which resemble the pattern of the monomeric CASC3SELOR. The sucrose gradient sedimentation profile (bottom) is based on quantification of MAGOH band intensities. The hexamer peak is indicated with a grey rectangle. Gradient conditions are specified on top. This exact experiment was done once.j. The in vivo mutation of ALYREF in the ALYREF–EJC interface (mutant ALYREFM-c+Δ d; see panel g for details) impairs its interaction with mRNP components. Wild-type FLAG-tagged ALYREFWT or the FLAG-ALYREFM-c+Δ d mutant were ectopically overexpressed in K562 cells, which also ectopically overexpressed THOC1-GFP. The two cell lines were used to prepare nuclear extract (NE), which were then treated with benzonase for 16 h at 4°C, including a final concentration of 5 mM MgCl2. The benzonase-treated extracts were then applied to anti-FLAG M2 resin for purification. Western blot analysis shows wild-type ALYREF or the mutant ALYREFM-c+Δ d (via their FLAG-tag), NCBP1, and EIF4A3. This experiment was done twice.k. The THO–UAP56 complex does not form a complex with ALYREFN in sucrose density gradients, suggesting that UAP56 binds the ALYREF UBM with low affinity as observed in yeast31. SDS-PAGE stained with Coomassie blue. The sucrose gradient sedimentation profile (bottom) is based on quantification of THOC2 and ALYREF band intensities. Gradient conditions are specified on top. This experiment was done twice. For gel source data, see Supplementary Figure 4.l. In vitro reconstitution of TREX–EJC–RNA. The recombinant proteins or subcomplexes were mixed as shown in Fig. 1d and applied to sucrose density gradient ultracentrifugation. SDS-PAGE analysis with Coomassie blue staining confirms the formation of a complex containing all eleven proteins subunits and a sedimentation coefficient of ~75 S. Gradient conditions are specified on top. This experiment was done four times.m. The ALYREF-UBM–UAP56 interaction is required to form the TREX–EJC–RNA complex in vitro. Sucrose gradient sedimentation profiles of (from top to bottom): ALYREFN–EJC–RNA, ALYREF55-182–EJC–RNA, THO–UAP56, THO–UAP56 with ALYREFN–EJC–RNA, and THO–UAP56 with ALYREF55-182–EJC–RNA. Gradient fractions were analyzed by SDS-PAGE and Coomassie staining. Bellow, sucrose gradient sedimentation profiles are based on quantifications of the EJC subunit MAGOH and THO complex subunit THOC2 band intensities. MAGOH intensities were multiplied by a factor of 3 for better visualization. Gradient fractions containing ALYREF–EJC–RNA (light grey), THO–UAP56 (light grey), or TREX–EJC–RNA (grey) are shown with rectangles. Gradient conditions are specified on top. This experiment was done five times.n. A monomeric THO complex (THOMonomer) does not form TREX–EJC–RNA complexes in vitro. Sucrose gradient sedimentation profiles of THOMonomer–UAP56 (see Methods for details) alone or in presence of ALYREFN–EJC–RNA, assembled on a 15nt ssRNA. Gradient fractions were analyzed by SDS-PAGE and Coomassie staining. THOMonomer–UAP56 did not form TREX–EJC–RNA complexes (compare to panel m). Below, sucrose gradient sedimentation profiles are based on quantifications of the EJC subunit MAGOH and THO complex subunit THOC2 band intensities. MAGOH intensities were multiplied by a factor of 3 for better visualization. Gradient conditions are specified on top. This experiment was done twice.
Supplier Page from Abcam for Anti-eIF4A3 antibody [EPR14302(B)]